The realities of the emerging healthcare marketplace are quickly being recognized. Layna Cook, with law firm, Baker, Donelson, Bearman, Caldwell & Berkowitz, PC, discussed these realities with her presentation, The Impact of Health Reform's State Exchanges.
The realities of the emerging healthcare marketplace are quickly being recognized. Layna Cook, with law firm, Baker, Donelson, Bearman, Caldwell & Berkowitz, PC, discussed these realities with her presentation, “The Impact of Health Reform’s State Exchanges.” Cook says that the Affordable Care Act (ACA) is essential in promoting adequate health coverage for as many Americans as possible. Implementation strategies like individual mandates, employer pay or play penalties, insurance market regulations, and Medicaid expansions are only few of the ways of ensuring increased coverage.
Exchanges, the online marketplaces for individuals and small groups to purchase insurance, will allow individuals to apply for premium subsidies and tax credits. As well, if states opt to run an exchange, they will have to include a Small Business Options Program (SHOP) exchange. SHOPs must meet all the requirements of individual exchanges, except those dealing with premium tax credits and cost-sharing reduction subsidies.
According to Cook, there will be implementation challenges for many stakeholders including the consumers, providers, states, and federal government. However, despite those challenges, by January 2015 all exchanges must be fully operational and self-sustaining.
Exchanges must also ensure health plans meet 2 basic requirements to be considered Quality Health Plans (QHPs). The first is that the issuer must demonstrate compliance with the minimum certification requirements. Second, the exchange must determine that the offered plan is specifically in the interest of qualified individuals and employers. Confirming these requirements will provide consumer benefits like network adequacy, transparency from the issuer, higher standards including that of an inability to discriminate, and other qualifiers that will aid buyers.
One of the final impacts Cook thinks Americans will see are essential health benefits (EHB). Beginning in 2014, all plans in the exchange must offer a standard set of benefits referred to as essential health benefits (EHB). Some of these benefits include ambulatory patient services, emergency services, pediatric services, and hospitalization. Benefit categories are organized by percentage of offered coverage, and out-of-pocket limits. These benefit categories are argued to:
The health reform’s state exchanges will greatly impact payers, patients, and providers. With the help of navigators and these new guidelines, however, it will ensure that all offered plans are in the best interest of individuals and employers.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Health Care Utilization and Cost of Diagnostic Testing for Respiratory Infections
September 17th 2025Syndromic reverse transcriptase–polymerase chain reaction tests for respiratory infections were associated with lower health care resource utilization and costs, implicating potential for improved value in patient care.
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Drug Interactions With Ibrutinib Common, Linked to Higher Infection Risk in CLL
September 16th 2025Drug interactions with ibrutinib may not shorten survival when managed carefully, though the significant increase in infection-related hospitalizations tied to CYP3A inhibitors signals an urgent need for closer monitoring, dose adjustment, and proactive infection prevention strategies.
Read More